About: ENHANCED ECG MONITORING OF COVID-19 PATIENTS

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: ENHANCED ECG MONITORING OF COVID-19 PATIENTS Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
title	ENHANCED ECG MONITORING OF COVID-19 PATIENTS
Creator	Lampert, Rachel Akar, Joseph Burr, Alicia Freeman, James Ganeshan, Raj Jain, Shashank Obasare, Edinrin Workman, Virginia Rosenfeld, Lynda Burr, Debiasi, Ralph Mbbs, Alicia
source	Elsevier; Medline; PMC
abstract	BACKGROUND: Many of the drugs being used in the treatment of the ongoing pandemic coronavirus disease 2019 (COVID-19) are associated with QT prolongation. Expert guidance supports ECG monitoring to optimize patient safety. OBJECTIVE: To establish an enhanced process for ECG monitoring of patients being treated for COVID-19. METHODS: We created an SBAR (Situation Background Assessment Recommendation Tool) identifying the indication for ECGs in COVID-19 patients, and tagged these ECGs to ensure prompt over reading and identification of those with QT prolongation (QTc >470 ms for QRS < 120 ms, QTc > 500 ms for QRS > 120 ms). This triggered a phone call from the electrophysiology service to the primary team to provide management guidance and a formal consultation if requested. RESULTS: During a 2-week period we reviewed 2006 ECGs, corresponding to 524 unique patients, of whom 103 (19.7%) met SBAR defined criteria for QT prolongation. When compared to those without QT prolongation, these patients were more often in the intensive care unit (58.3% vs 35.4%) and more likely to be intubated (31.1 vs 18.1%). Fifty patients with QT prolongation (48.5%) had electrolyte abnormalities, 98 (95.1%) were on COVID-19 related QT prolonging medications, and 62 (60.2%) were on 1-4 additional non COVID-19 related QT prolonging drugs. Electrophysiology recommendations were given to limit modifiable risk factors. No patient developed torsade de pointes. CONCLUSION: This process functioned efficiently, identified a high percentage of patients with QT prolongation, and led to relevant interventions. Arrhythmias were rare. No patient developed torsade de pointes.
has issue date	2020-05-06(xsd:dateTime)
bibo:doi	10.1016/j.hrthm.2020.04.047
bibo:pmid	32387247
has license	no-cc
sha1sum (hex)	ee42806d9d780ba4a36ec94a0ebe907249ba6626
schema:url	https://doi.org/10.1016/j.hrthm.2020.04.047
resource representing a document's title	ENHANCED ECG MONITORING OF COVID-19 PATIENTS
has PubMed Central identifier	PMC7200355
has PubMed identifier	32387247
schema:publication	Heart Rhythm
resource representing a document's body	covid:ee42806d9d780ba4a36ec94a0ebe907249ba6626#body_text
is schema:about of	named entity 'optimize' named entity 'Author' named entity 'ECG' named entity 'BEING' named entity 'TREATMENT' named entity 'OPTIMIZE' named entity 'patient safety' named entity 'pandemic' named entity 'ECG' named entity 'Corresponding' named entity 'ECG monitoring' named entity 'patient safety' named entity 'COVID-19' named entity 'intubated' named entity 'repolarization' named entity 'hypokalemia' named entity 'QT prolongation' named entity 'torsade de pointes' named entity 'ion channels' named entity 'torsade de pointes' named entity 'COVID-19' named entity 'QT prolongation' named entity 'Electrocardiogram' named entity 'COVID-19' named entity 'electrophysiologic' named entity 'SBAR' named entity 'COVID-19' named entity 'electrolyte' named entity 'ECG' named entity 'COVID-19' named entity 'arrhythmias' named entity 'QTc' named entity 'QTc' named entity 'COVID-19 pandemic' named entity 'QT prolongation' named entity 'COVID-19 pandemic' named entity 'Hypomagnesemia' named entity 'QTc' named entity 'ECG monitoring' named entity 'ECG' named entity 'ECGs' named entity 'ECG' named entity 'QT prolongation' named entity 'ECG' named entity 'retrospective study' named entity 'intensive care unit' named entity 'ECG monitoring' named entity 'ECGs' named entity 'mEq/L' named entity 'single center' named entity 'QTc' named entity 'ICU' named entity 'IKr' named entity 'QTc' named entity 'QTc' named entity 'QTc' named entity 'QTc' named entity 'corrected QT interval' named entity 'Box plot' named entity 'ECG' named entity 'ECG' named entity 'sinus tachycardia' named entity 'QT prolongation' named entity 'telemetry' named entity 'coronavirus disease 2019' named entity 'QT PROLONGATION' named entity 'QT prolongation' named entity 'ongoing pandemic' named entity 'USED' named entity 'ONGOING'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software